Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial (Q30053056)
scientific article (publication date: November 2012)
Language:
Current Data About Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
(P31) (Q13442814)

(P50) (Q30001859)
(P1545) 6
(P1932) Hans-Peter Hartung
(P248)
(P813) Thursday, May 25, 2017

(Q59162815)
(P1545) 12
(P1932) Gavin Giovannoni
(P248)
(P813) Thursday, May 25, 2017

(Q20985921)
(P1545) 9
(P1932) Howard L Weiner
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(Q83945935)

(Q41721885)
(P1545) 7
(P1932) Eva Havrdova
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P304) 1819-1828
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P407) (Q1860)

(P433) 9856
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P478) 380
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P577) +2012-11-00T00:00:00Z
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P921) (Q42824827)

(Q18555066)

(Q8277)

(P1433) (Q939416)
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P1476) "Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial" (language: en)
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P2093) Jeffrey A Cohen
(P1545) 1
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Alasdair J Coles
(P1545) 2
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Douglas L Arnold
(P1545) 3
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Christian Confavreux
(P1545) 4
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Edward J Fox
(P1545) 5
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Krzysztof W Selmaj
(P1545) 8
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Elizabeth Fisher
(P1545) 10
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Vesna V Brinar
(P1545) 11
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Miroslav Stojanovic
(P1545) 13
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Bella I Ertik
(P1545) 14
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Stephen L Lake
(P1545) 15
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

David H Margolin
(P1545) 16
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

Michael A Panzara
(P1545) 17
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

D Alastair S Compston
(P1545) 18
(P248)
(P854) https://doi.org/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, May 25, 2017

(P2860) (Q51987968)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q51890331)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q48087197)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q28144207)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q50766232)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q33381736)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q33400373)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q22252938)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q22241644)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q40810823)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q53482190)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q52009627)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q44825022)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q78571161)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q40047751)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q33497070)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q57492006)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q30922892)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q78571167)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q43281208)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q28271008)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q50527638)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q28278620)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q34581641)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q85072553)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q54146573)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q36026719)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q33994423)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q57762303)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q82371844)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

(Q46302050)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961769-3
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article (publication date: November 2012)

External Links
(P356) 10.1016/S0140-6736(12)61769-3
(P698) 23122652
(P3181) 52824